Skip to main content
. 2021 May 21;13(11):2540. doi: 10.3390/cancers13112540

Table 2.

Progression-free survival.

PFS (Years) 95%-CI (Years) p-Value
Patient age
>50 years 5.4 ± 1.2 3.0–7.7
≤50 years 4.6 ± 0.4 3.8–5.3 p = 0.56
Pattern of CE on MRI
patchy/faint, focal 3.9 ± 0.5 2.8–4.9
none 5.0 ± 0.5 4.1–6.0 p = 0.07
5-ALA fluorescence
yes 2.3 ± 0.7 1.0–3.7
no 5.0 ± 0.4 4.2–5.7 p = 0.01
Extent of resection
complete 5.0 ± 0.5 4.1–5.9
incomplete 4.3 ± 0.6 3.2–5.4 p = 0.47
Histological subtype
oligodendroglioma IDH-mutant 5.8 ± 0.6 4.7–6.9
diffuse astrocytoma IDH-mutant 3.9 ± 0.5 2.8–4.9 p = 0.04
IDH mutational status
wildtype 1.9 ± 0.6 0.7–3.0
mutant 4.8 ± 0.4 4.0–5.5 p = 0.10

Bold: highlight significant values.